Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ikaros family zinc finger protein 1 is an essential transcription factor governing lymphoid development through direct control over gene expression programs required for immune cell differentiation. Its structural integrity—particularly its six-zinc-finger motif—is vital for both DNA binding specificity/functionality and dimerization capacity. Loss-of-function alterations drive susceptibility/progression of acute lymphoblastic leukemia while germline defects cause primary immunodeficiencies. As such, it serves both as a biological master regulator within hematopoiesis/immunity pathways and an important clinical biomarker/prognostic indicator across several blood disorders.
Not applicable (transcription factor, not directly druggable with conventional small molecules)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ikaros Family Zinc Finger Protein 1 (IKZF1).